For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) today announced that following an application to The Stock Exchange of Hong Kong Limited (the 'Stock ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Nancy L. Lewis, MD, MBS, FACP, reflects on the career journey that led her to her new role as chief scientific officer (CSO) ...

For the past year, the pharmaceutical industry has wrestled with Washington, as President Donald Trump has demanded that drug ...

IBT's Ailsa Craig and Marek Poszepczynski give their key stock picks as companies move on from the science to commercial ...

In the early 1960s, Norwegian physician Kåre Berg, M.D., was trying to identify new blood types when he accidentally ...

A research team led by Prof. Sangwon Seo of the Department of Physics and Chemistry at DGIST has developed a catalytic ...

Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive ...

On April 9, 2026, Oxford BioTherapeutics announced a multi-year collaboration with Bristol Myers Squibb focused on the discovery and development of T-cell engager therapies for solid tumors. 1 ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the first cohort of healthy volunteers ...